🇺🇸 FDA
Patent

US 11078245

Colon and pancreas cancer peptidomimetics

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 11078245 (Colon and pancreas cancer peptidomimetics) held by PRECISION BIOLOGICS, INC. expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRECISION BIOLOGICS, INC.
Grant date
Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K38/00, A61K39/0011, A61K45/06